• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biofrontera AG

+ Add to Watchlist

B8F:GR

1.943 EUR 0.009 0.46%

As of 13:20:02 ET on 01/26/2015.

Snapshot for Biofrontera AG (B8F)

Open: 2.000 Day's Range: 1.912 - 2.055 Volume: 150,895
Previous Close: 1.952 52wk Range: 1.912 - 4.148 1-Yr Rtn: -43.19%

Stock Chart for B8F

No chart data available.
  • B8F:GR 2.000
  • 1D
  • 1M
  • 1Y
1.952
Interactive B8F Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B8F

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.5000
Est. EPS (EUR) (12/2014) -0.4650
Est. PEG Ratio -
Market Cap (M EUR) 42.44
Shares Outstanding (M) 22.20
30 Day Average Volume 26,670
Price/Book (mrq) 8.2573
Price/Sale (ttm) 12.5740
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B8F

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for B8F

Biofrontera AG develops drugs for dermatological and inflammatory diseases.

Hermann LuebbertChairman-Mgmt BoardThomas SchafferCFO/Member-Mgmt Board
More Company Profile & Key Executives for B8F

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil